Search details
1.
Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors.
Cancer
; 128(17): 3158-3169, 2022 09 01.
Article
in English
| MEDLINE | ID: mdl-35775874
2.
Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center.
Breast Cancer Res Treat
; 185(1): 215-227, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32939592
3.
Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035).
Gynecol Oncol Rep
; 32: 100546, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32083163
4.
A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer.
Clin Breast Cancer
; 20(3): 238-245, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32113750
5.
Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer.
Gynecol Oncol Rep
; 29: 118-122, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31467965
6.
Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial.
Clin Breast Cancer
; 19(6): 399-404, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31235441
Results
1 -
6
de 6
1
Next >
>>